Skip to main content
OpenTrials

Clinical trial condition

Varicella Zoster Virus Infection

Explore clinical trials studying Varicella Zoster Virus Infection. Study availability and eligibility vary by location and protocol.

345 public trials 42 recruiting studies
Refine in advanced search Browse all conditions

Varicella Zoster Virus Infection trial results

Recruiting

SkyVaricella® (NBP608) Vaccine With Lower Potencies in Healthy Children Aged 12 Months to 12 Years

NCT07415252

Conditions
Chickenpox, DNA Virus Infections, Herpesviridae Infections, +4 more
Locations
  • San Pedro Sula, site 101 San Pedro Sula, Cortés Department, Honduras
  • Tegucigalpa, site 102 Tegucigalpa, Francisco Morazán Department, Honduras
  • Manila, site 301 Manila, National Capital Region, Philippines
  • Quezon City, site 302 Quezon City, National Capital Region, Philippines
View all 14 locations
View Trial Details
Recruiting

Phase III Clinical Trial of Lyophilized Herpes Zoster mRNA Vaccine in Adults Aged 40 Years or Above

NCT07817108

Conditions
Chickenpox, DNA Virus Infections, Herpesviridae Infections, +4 more
Locations
  • Shandong Center for Disease Control and Prevention Jinan, China
  • Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention Nanning, China
  • Hebei Province Center for Disease Control and Prevention Shijiazhuang, China
  • Zhejiang Center for Disease Control and Prevention Zhejiang, China
View Trial Details
Recruiting

A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine, When Administered as Intramuscular Injection to Healthy Children 15 Months to 6 Years of Age

NCT07406360

Conditions
Chickenpox, DNA Virus Infections, Herpesviridae Infections, +19 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Walnut Creek, California, United States
  • GSK Investigational Site Miami, Florida, United States
  • GSK Investigational Site Miami, Florida, United States
View all 17 locations
View Trial Details
Recruiting

A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine and a Marketed Measles, Mumps and Rubella Vaccine When Administered as Intramuscular Injection to Healthy Children 12 to 15 Months of Age

NCT06855160

Conditions
Chickenpox, DNA Virus Infections, Herpesviridae Infections, +3 more
Locations
  • GSK Investigational Site Tucson, Arizona, United States
  • GSK Investigational Site Huntington Park, California, United States
  • GSK Investigational Site Sherman Oaks, California, United States
  • GSK Investigational Site Coral Gables, Florida, United States
View all 22 locations
View Trial Details
Recruiting

A Study on the Immune Response and Safety of the Second Dose of an Investigational Chickenpox Vaccine When Given to Healthy Children 3 Months After a First Dose at 12 to 15 Months of Age

NCT06806137

Conditions
Chickenpox, DNA Virus Infections, Herpesviridae Infections, +3 more
Locations
  • GSK Investigational Site Salvaleón de Higüey, La Altagracia Province, Dominican Republic
  • GSK Investigational Site Constanza, Dominican Republic
  • GSK Investigational Site Santo Domingo Oeste, Dominican Republic
  • GSK Investigational Site San Pedro Sula, Honduras
View Trial Details
Recruiting

A Study to Evaluate the Effect of Recombinant Zoster Vaccine on New Diagnosis of Dementia in an Older Adult Population Aged 76 Years or Older in Finland

NCT07502560

Conditions
Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +12 more
Locations
  • GSK Investigational Site Espoo, Finland
  • GSK Investigational Site Helsinki, Finland
  • GSK Investigational Site Jarvenpaa, Finland
  • GSK Investigational Site Kokkola, Finland
View Trial Details

Related conditions